AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05997238 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg triamcinolone
Description: 20mg triamcinolone was added to the preparation. Mix 20mg triamcinolone and the basic formula to make a mixed preparation. The base formula contains 150mg ropivacaine and 0.5mg epinephrine. Add normal saline and mix to 80ml.
Study NCT05997238 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 40mg triamcinolone
Description: 40mg triamcinolone was added to the preparation. Mix 40mg triamcinolone and the basic formula to make a mixed preparation. The base formula contains 150mg ropivacaine and 0.5mg epinephrine. Add normal saline and mix to 80ml.
Study NCT05997238 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 80mg triamcinolone
Description: 80mg triamcinolone was added to the preparation. Mix 80mg triamcinolone and the basic formula to make a mixed preparation. The base formula contains 150mg ropivacaine and 0.5mg epinephrine. Add normal saline and mix to 80ml.
Study NCT05522803 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: TMS followed by sham TMS
Description: Transcranial Magnetic Stimulation followed by sham TMS
Study NCT05088824 — intervention group
Intervention type: PROCEDURE
Intervention: hernia repair by desarda technique
Description: It involves use of undetached strip of external oblique aponeurosis to strengthen the posterior wall of the inguinal canal which is based on the physiological principles. This is a physiological repair and is tension free, can be used in strangulated hernia
Study NCT05649982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALVA
Description: Behavioural digital self-help intervention
Study NCT05522803 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Sham TMS followed by TMS
Description: Sham Transcranial Magnetic Stimulation followed by TMS
Study NCT06634992 — intervention group
Intervention type: OTHER
Intervention: Oral immunotherapy
Description: Clinical Follow up
Study NCT05325008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immunosuppression reduction/modification + intravenous immunoglobulin
Description: Participants will receive intravenous immunoglobulin along with immunosuppression reduction/modification.
Study NCT05325008 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Immunosuppression reduction/modification
Description: Participants will receive immunosuppression reduction/modification.
Study NCT06635382 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Universal single bond adhesive
Description: Will be applied and light cured for 20 seconds.
Study NCT06635382 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Universal single bond adhesive
Description: Will be applied and light cured for 20 seconds.
Study NCT06635382 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DMSO
Description: DMSO application on tooth followed by active application of universal single bond adhesive and light cured for 20 seconds.
Study NCT04797858 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COVID-19 self-test
Description: 5 COVID-19 self-test kits will be given to participants after they have been tested for COVID-19. Participants will be instructed to give test kits to others in their social networks who are symptomatic, exposed to COVID-19, or otherwise at high risk of COVID-19.
Study NCT04797858 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 test referral
Description: 5 test referral cards and text messages on how to obtain COVID-19 testing will be given to participants after they have been tested for COVID-19. These cards and text messages will have information on how to obtain free COVID-19 tests at local testing sites. Participants will be instructed to give out referral cards and text messages to others in their social networks to obtain testing.
Study NCT05559216 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Plyometric Training
Description: Plyometric training exercises are being given to the participants to see the changes after the 8 week period
Study NCT06176859 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: HIV PrEP Delivery
Description: To test an end-to-end decentralized delivery service for pre-exposure prophylaxis (PrEP) to safely increase PrEP access and use among priority populations in South Africa.
Study NCT06176859 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HIV PrEP Delivery
Description: To test an end-to-end decentralized delivery service for pre-exposure prophylaxis (PrEP) to safely increase PrEP access and use among priority populations in South Africa.
Study NCT05085860 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous training (MICT)
Description: Participants will engage in exercise and record AF symptoms prospectively over 7 days
Study NCT05085860 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Description: Participants will engage in exercise and record AF symptoms prospectively over 7 days
Study NCT05580926 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Watch your Weight During Holidays
Description: Participants in this group will have an individual face-to-face session (with a maximum duration of half an hour) and a face-to-face group session. This intervention will include strategies for self-monitoring (body weight, diet and physical activity), information on healthy lifestyles, as well as information about the energy contained in local festive foods and their equivalent in minutes of physical activity or steps per day.~Participants will be asked to weight themselves at least twice a week, as a form of self-monitoring of weight, from the start of the intervention. They will have access to weekly forms with boxes, where they can fill in the data obtained for each day of weight self-monitoring, energy intake restriction report and minutes of physical activity performed.
Study NCT05580926 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control Group (minimal intervention)
Description: Participants in this group will receive a printed information, as well as a PDF file, brochure during a face-to-face session at the beginning of the 8-week period. This information will be about having a healthy eating based on the norm for health promotion and education for healthy eating in Mexico (NOM-043-SSA2-2012).
Study NCT05068206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK105 injection
Description: AK105 is programmed death 1（PD-1） monoclonal antibody
Study NCT05068206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib hydrochloride capsule
Description: Anlotinib is small molecule multi-target tyrosine kinase inhibitor.
Study NCT05068206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CapeOX
Description: CapeOX is Capecitabine+Oxaliplatin. Capecitabine is a kind of fluorouracil drug, and Oxaliplatin is a kind of platinum anticancer drug.
Study NCT05068206 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CapeOX
Description: CapeOX is Capecitabine+Oxaliplatin. Capecitabine is a kind of fluorouracil drug, and Oxaliplatin is a kind of platinum anticancer drug.
Study NCT05068206 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab
Description: Bevacizumab is a recombinant human monoclonal antibody.
Study NCT06356870 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: BMAC MIXED WITH ALLOGRAFT
Description: Study group
Study NCT06356870 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cancellous bone from anterior iliac crest
Description: Control group
Study NCT06052878 — intervention group
Intervention type: OTHER
Intervention: Parental telephone interview with standardized parental questionnaire from the Behaviour Rating Inventory of Executive Function (BRIEF)
Description: The Behaviour Rating Inventory of Executive Function (BRIEF) is a parental questionnaire that assesses the executive functions of children aged 5 to 18 years old. It consists of 86 questions grouped into 8 scales: inhibition, flexibility, emotional control, initiation, material organization, working memory, planning/organization, and monitoring. It provides information on a global scale (score) regarding subtle and subclinical changes in various executive functions.
Study NCT06052878 — intervention group
Intervention type: OTHER
Intervention: Parental questionnaire about their child's cognitive functioning in their daily life and medical history.
Description: Standardized questionnaire includes : The child's medical history and cognitive functioning (at school, parental home, and during extracurricular activities), home environment, parent's child socioeconomic status and emotional climate.
Study NCT02059694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyaluronidase
Study NCT02059694 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 2 mL of lidocaine 2% with epinephrine 1:100,000 without rHuPH20
Study NCT06526715 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Morton extension
Description: A Morton extension with a height of 5 mm was insert from the proximal area of the first metatarsal head to the base of the proximal phalanx of the Hallux of the subjects' bare feet using a paper bandage. The material, shape, size, and thickness of the Morton Extension were the same.
Study NCT06529640 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SCTG followed by coronally postionting flap
Description: The SCTG will be harvested from the palate followed by coronally postionting flap
Study NCT06529640 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: periosteal flap followed by coronally postionting flap
Description: he periosteal pedicle graft obtained is then turned over the exposed root surface then followed by coronally postionting flap
Study NCT05051566 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3502970
Description: Administered orally.
Study NCT05051566 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole
Description: Administered orally.
Study NCT06082050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YOLT-201
Description: Infusion of YOLT-201 at Day 1。
Study NCT06043050 — intervention group
Intervention type: DRUG
Intervention: Platelets
Description: Observational data: all platelet transfusions recorded in routine care medical file data.
Study NCT05956340 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Research interview
Description: Research interview to capture speech data with high quality cardioid headset microphone
Study NCT05017740 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ICSI
Description: In ICSI, the sperm is chosen based on motility and gross morphology to be inseminated directly into the cytoplasm of the oocyte.
Study NCT05017740 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PICSI
Description: In PICSI, the sperm is selected via hyaluronic binding before insemination into the cytoplasm of the oocyte.
Study NCT06524024 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tumor polypeptide pool induced DC-CTL cell injection
Description: In this study, DC-CTL cells were injected once a day for two consecutive days, 1-2 days after study participants received a conventional antitumor regimen, and subcutaneous injections of DC cells were administered before a second infusion of DC-CTL cells. A total of about 4-6 cycles of cell infusion are required
Study NCT05562440 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Focus Group Discussion
Description: Each focus group will consist up to five participants in every session, two sessions each for both low and high risk group. Every FGD sessions will last for 1 to 2 hours and be conducted in Indonesian, and will be recorded. Both groups will be asked the following questions: 1) What is your opinion regarding the clarity of information in the dummy breast cancer risk prediction report?; 2) What is your opinion regarding the completeness of information in the dummy breast cancer risk prediction report?; and 3) What is your impression regarding the results presented in the dummy breast cancer risk prediction report?.
Study NCT06035133 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CapeOX + cetuximab
Description: CapeOX + cetuximab for RAS wild-type patients and CapeOX + cetuximab for MSI-H patients. The CapeOX regimen: Oxaliplatin 130 mg/m2, intravenous injection, day 1; capecitabine 1000 mg/m2, oral, twice daily, days 1 through 14; once every 3 weeks.
Study NCT06035133 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CapeOX + bevacizumab
Description: CapeOX + bevacizumab for RAS mutant patients. The CapeOX regimen: Oxaliplatin 130 mg/m2, intravenous injection, day 1; capecitabine 1000 mg/m2, oral, twice daily, days 1 through 14; once every 3 weeks.
Study NCT06035133 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: radiotherapy
Study NCT05958784 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-Phenylalanine
Description: 100 mg/kg
Study NCT05584397 — intervention group
Intervention type: PROCEDURE
Intervention: Venipuncture
Description: Draw of peripheral blood (about 20 ml and 40 ml, during the screening and procedure visits, respectively).
Study NCT05584397 — intervention group
Intervention type: PROCEDURE
Intervention: Targeted physical medical exam
Description: Study participants will be undergoing a physical exam where vitals will be recorded (e.g. temperature, blood pressure, heart rate). The registered nurse (RN) will also perform auscultation of heart and lungs.~Study participants will be also asked to fill out a survey with questions related to his/her medical history, current use of medications, sexual history and substance abuse.
Study NCT05584397 — intervention group
Intervention type: PROCEDURE
Intervention: Urine pregnancy test
Description: Women of childbearing potential will be asked to run an urine pregnancy test during the second (procedure) visit. Pregnant women will not be allowed to participate in the study.
Study NCT05584397 — intervention group
Intervention type: PROCEDURE
Intervention: Anoscopy
Description: The anoscopy is an examination using a small, rigid, tubular instrument called anoscope (also called an anal speculum). This is inserted a few inches into the rectum in order to collect some small samples of mucosal tissue. We will collect 5 rectum biopsy samples and one cytobrush.
Study NCT05584397 — intervention group
Intervention type: PROCEDURE
Intervention: Esophagogastroduodenoscopy (EGD)
Description: The EGD involves looking at the esophagus, stomach, and first and second portion of the duodenum. This procedure involves the use of an endoscope to remove small tissue samples. This procedure uses conscious sedation drugs given by a vein in the arm. The procedure takes about 1½-2 hours, including time for recovery. We will collect 5 duodenal biopsies and one cytobrush.
Study NCT05054361 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MAIT cells analysis
Description: For FACS analysis, MAIT cells will be identified as CD3+ CD4- CD161high Vα7.2+ T cells. Surface markers will be analyzed to determine their activation status (CD25, CD69, CD44), their exhaustion (PD1, KLRG1, TIM3), their migration capacity (CCR6), and their proliferation and survival will be analyzed by Ki67 and BCL2 expression.
Study NCT05054361 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MAIT cytokines production analysis
Description: Cytokine production will be assessed after PMA-ionomycin activation, followed by intracytoplasmic staining with antibodies against IL-2, IFN-γ TNF-α, IL-2, IL-4, IL-10, IL-13, IL-17 and granzyme B. To determine the capacity of MAIT cells to response to TCR stimulation (exhaustion), in vitro stimulation will be performed in the presence of specific bacterial ligands. Activation marker expression will be analyzed by FACS and cytokines released in the supernatant by Cytometry based assay.
Study NCT05738564 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epinephrine Inhalation Solution
Description: epinephrine prepared solution mixed with lidocaine (EL) Otrivin adult nasal drops 0.1Otrivin adult nasal drops 0.1%, 10 ml of 1 mg/ml; Novartis Consumer Health, UK Ltd, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK) in each nostril in the pre-induction room just before the induction of anesthesia
Study NCT04799470 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Novel DBS stimulation patterns
Description: Stimulation patterns
Study NCT05161260 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga Breathing
Description: For the12 weeks, participants will be asked to use the mobile study app, completing 3, 10 minute exercises, 5 days a week. Participants in the Yoga Breathing group will practice a breathing exercise guided by the mobile study application. The application will also send nudges and reminders throughout the day. Participants will engage with the research study app along with other participants in groups of 2-7 at their own convenience. Participants may practice their breathing activity with either a group of participants, through the video conferencing feature of the app, or on their own. The study instructor may join sessions on a random basis to ensure compliance with the technique and to clarify any questions participants may have.
Study NCT05161260 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Control
Description: For the12 weeks, participants will be asked to use the mobile study app, completing 3, 10 minute exercises, 5 days a week. Participants in the Attention Control group will practice a mindfulness exercise guided by the mobile study application. The application will also send nudges and reminders throughout the day. Participants will engage with the research study app along with other participants in groups of 2-7 at their own convenience. Participants may practice their mindfulness activity with either a group of participants, through the video conferencing feature of the app, or on their own. The study instructor may join sessions on a random basis to ensure compliance with the technique and to clarify any questions participants may have.
Study NCT04921683 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BX Pulsar 1002 (LIFUP) Low intensity Focused Ultrasound Pulsation
Description: Administration of LIFUP will be performed at the bedside using frameless stereotaxy. Specifically, the LIFUP transducer will be fit to the patient's head employing adjustable straps, and will be positioned over the patient's left temporal bone, over the temporal window in order to minimize bone absorption and refraction. Accurate aiming will be ensured employing the BrainSight neuronavigation device, customized for tracking our LIFUP transducer (total \~10 min). Once satisfactory aiming is achieved, the LIFUP exposure will be initiated employing the settings described previously (which meet the FDA safety limits: ISPPA \<= 190W/cm2, ISPTA \<= 0.72W/cm2). Accurate aiming will be monitored in real-time throughout exposure using the Brain Sight Neuronavigation interface.
Study NCT06278402 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Description: Oral tofacitinib 5mg twice daily for treatment of alopecia areata, totalis and universalis.
Study NCT06208761 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Triphala capsule supplementation and high-intensity interval training
Description: Triphala capsule supplementation is categorized in dietary supplement but and high-intensity interval training is included as other
Study NCT06208761 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Triphala capsule supplementation and high-intensity interval training
Description: Triphala capsule supplementation is categorized in dietary supplement but and high-intensity interval training is included as other
Study NCT06177041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M108 monoclonal antibody
Description: M108 monoclonal antibody will be administered as a minimum 2-hour IV infusion.
Study NCT06177041 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered as a minimum 2-hour IV infusion.
Study NCT06177041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin will be administered as a 2-hour IV infusion.
Study NCT06177041 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oxaliplatin
Description: Oxaliplatin will be administered as a 2-hour IV infusion.
Study NCT06177041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine will be administered orally twice daily (bid).
Study NCT06177041 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Capecitabine
Description: Capecitabine will be administered orally twice daily (bid).
Study NCT06360731 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 4-7-8 breathing exercise technique and informative session on tinnitus
Description: Participants in experimental group will be individually provided with informative session on tinnitus for one hour by researchers. During the informative session, the participants will be given general information about tinnitus and will be informed about the possible causes, symptoms, diagnosis, therapy, or treatment processes, and coping methods. The participants will be also given a printed informative brochure on tinnitus. In the same session, after one hour of informative session, the 4-7-8 breathing exercise method will be demonstrated by the same researchers. In addition, a video showing how to perform the 4-7-8 breathing exercise technique will be sent as a text message to their cell phones.
Study NCT06360731 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Informative session on tinnitus
Description: Participants in control group will be individually provided with informative session on tinnitus only for one hour by researchers G.K. and G.S.U. from both clinics. During the informative session, the participants will be given general information about tinnitus and inform about the possible causes, symptoms, diagnosis, therapy, or treatment processes, and coping methods. The participants will be also given a printed informative brochure on tinnitus.